Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer

被引：0
|
作者：
Maria Karsten
Michelle Stempel
Julia Radosa
Sujata Patil
Tari A. King
机构：
[1] Memorial Sloan Kettering Cancer Center,Breast Service, Department of Surgery
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Biostatistics
来源：
Annals of Surgical Oncology | 2016年 / 23卷
关键词：
Breast Cancer; Breast Cancer Mortality; Recurrence Score; Bilateral Breast Cancer; Progesterone Receptor Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：471 / 476
页数：5
相关论文
共 50 条
  • [11] Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results
    Kamaljeet Singh
    Xin He
    Elizabeth T. Kalife
    Shahrzad Ehdaivand
    Yihong Wang
    C. James Sung
    Breast Cancer Research and Treatment, 2018, 168 : 29 - 34
  • [12] Is There a Role for Oncotype Dx Testing in Invasive Lobular Carcinoma?
    Conlon, Niamh
    Ross, Dara S.
    Howard, Jane
    Catalano, Jeffrey P.
    Dickler, Maura N.
    Tan, Lee K.
    BREAST JOURNAL, 2015, 21 (05): : 514 - 519
  • [13] Clinical Impact of a Novel Model Predictive of Oncotype DX Recurrence Score in Breast Cancer
    Yamamoto, Shinya
    Chishima, Takashi
    Shibata, Yukako
    Harada, Fumi
    Takeuchi, Hideki
    Yamada, Akimitsu
    Narui, Kazutaka
    Misumi, Toshihiro
    Ishikawa, Takashi
    Endo, Itaru
    IN VIVO, 2021, 35 (04): : 2439 - 2444
  • [14] Relationship of histologic grade and histologic subtype with oncotype Dx recurrence scoreI3/4 retrospective review of 863 breast cancer oncotype Dx results
    Singh, Kamaljeet
    He, Xin
    Kalife, Elizabeth T.
    Ehdaivand, Shahrzad
    Wang, Yihong
    Sung, C. James
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (01) : 29 - 34
  • [15] The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
    Crolley, Valerie E.
    Marashi, Husam
    Rawther, Shabbir
    Sirohi, Bhawna
    Parton, Marina
    Graham, Janine
    Vinayan, Anup
    Sutherland, Stephanie
    Rigg, Anne
    Wadhawan, Anshu
    Harper-Wynne, Catherine
    Spurrell, Emma
    Bond, Hannah
    Raja, Fharat
    King, Judy
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (03) : 809 - 817
  • [16] Adjuvant Chemotherapy for Patients with Breast Cancer Based on Clinical and Evolving Oncotype DX Criteria
    Zekri, Jamal
    Al-Foheidi, Meteb
    Alata, Maaz
    Zabani, Reem
    Rasmy, Ayman
    BREAST CARE, 2020, 15 (06) : 642 - 647
  • [17] Overview of the use of Oncotype DX® as an additional treatment decision tool in early breast cancer
    Markopoulos, Christos
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (02) : 179 - 194
  • [18] Periductal Stromal Tumor of the Breast with Synchronous Bilateral Breast Cancer
    Ki, So Yeon
    Lim, Hyo Soon
    Lee, Ji Shin
    Park, Seo Yeon
    Yim, Nam Yeol
    Heo, Suk Hee
    Park, Min Ho
    Cho, Jin Seong
    Shin, Sun Hyoung
    ANTICANCER RESEARCH, 2014, 34 (07) : 3635 - 3639
  • [19] Factors influencing Oncotype DX use in the management of early breast cancer: A single centre experience
    Zhu, Xiaofu
    Dent, Susan
    Paquet, Lise
    Zhang, Tinghua
    Graham, Nadine
    Song, Xinni
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (15) : 2544 - 2549
  • [20] Comparison of Oncotype DX With Modified Magee Equation Recurrence Scores in Low-Grade Invasive Carcinoma of Breast
    Hou, Yanjun
    Zynger, Debra L.
    Li, Xiaoxian
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 148 (02) : 167 - 172
12345